The authors investigated EPA levels at the time of STEMI were associated with a lower rate of major adverse cardiovascular events (MACE), all-cause mortality, and readmission for cardiovascular (CV) causes in a 3 years’ follow-up. The study included 944 patients with STEMI with an average age of 61. At the follow-up, 211 participants had MACE, 108 died, and 130 were readmitted for CV causes. Their model showed that EPA at the time of STEMI was inversely associated with both incident MACE and CV readmission.
In conclusion, consuming food that is rich in fatty omega-3 acid might lead to a decreased risk of MACE and CV during STEMI.
Lázaro, I., Rueda, F., Cediel, G., Ortega, E., García-García, C., Sala-Vila, A., & Bayés-Genís, A. (2020). Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology, 76(18), 2089-2097.
In conclusion, consuming food that is rich in fatty omega-3 acid might lead to a decreased risk of MACE and CV during STEMI.
Lázaro, I., Rueda, F., Cediel, G., Ortega, E., García-García, C., Sala-Vila, A., & Bayés-Genís, A. (2020). Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology, 76(18), 2089-2097.